Brookline Capital Acquisition Corp. (NASDAQ:BCAC) Sees Significant Increase in Short Interest

Brookline Capital Acquisition Corp. (NASDAQ:BCACGet Rating) was the recipient of a significant increase in short interest during the month of April. As of April 30th, there was short interest totalling 28,000 shares, an increase of 28.4% from the April 15th total of 21,800 shares. Currently, 0.4% of the company’s stock are sold short. Based on an average daily trading volume, of 49,100 shares, the days-to-cover ratio is currently 0.6 days.

Shares of BCAC stock opened at $10.11 on Tuesday. The business has a 50 day moving average of $10.09 and a two-hundred day moving average of $10.03. Brookline Capital Acquisition has a 52 week low of $9.80 and a 52 week high of $10.12.

A number of hedge funds have recently modified their holdings of BCAC. Millennium Management LLC acquired a new position in Brookline Capital Acquisition in the second quarter valued at approximately $351,000. Berkley W R Corp boosted its stake in Brookline Capital Acquisition by 35.3% in the third quarter. Berkley W R Corp now owns 74,426 shares of the company’s stock valued at $740,000 after acquiring an additional 19,425 shares during the period. Jane Street Group LLC boosted its stake in Brookline Capital Acquisition by 1.8% in the third quarter. Jane Street Group LLC now owns 75,653 shares of the company’s stock valued at $753,000 after acquiring an additional 1,324 shares during the period. Schonfeld Strategic Advisors LLC acquired a new position in Brookline Capital Acquisition in the third quarter valued at approximately $155,000. Finally, Wolverine Asset Management LLC boosted its stake in Brookline Capital Acquisition by 7.8% in the fourth quarter. Wolverine Asset Management LLC now owns 33,843 shares of the company’s stock valued at $338,000 after acquiring an additional 2,437 shares during the period. Institutional investors own 51.83% of the company’s stock.

About Brookline Capital Acquisition (Get Rating)

Brookline Capital Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities in the life sciences industry. The company was founded in 2020 and is based in New York, New York.

Recommended Stories

Receive News & Ratings for Brookline Capital Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Brookline Capital Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.